|By PR Newswire||
|March 26, 2014 07:00 PM EDT||
DUBLIN, March 26, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/7rc6qw/cancer_stem_cell) has announced the addition of the "Concise Analysis of the International Cancer Stem Cell Trends" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of the market are the rising affliction of diseases such as cancer and the reimbursement assistance by regulatory organizations in developed nations including the US and Europe.
Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal and driving tumorigenesis. In the previous research studies, rare CSCSs have been isolated from several human tumors such as brain, breast, colon and haematopoietic cancers. CSCs are believed to survive in tumors as a completely distinct population and might cause metastasis and relapse by producing new tumors.
In addition, the report highlights the exponential rise in research on Cancer Stem Cells (CSCs), and the design of novel drugs to treat CSCs. Major players in the field include Boston Biomedical Inc., Macrogenics, and Verastem, Inc.
Key Topics Covered:
1. CANCER STEM CELLS - A FOCUS REPORT
2. TECHNOLOGY OVERVIEW
3. MARKET INFORMATION
4. NOTEWORTHY MARKET PARTICIPANTS
5. CORPORATE/RESEARCH INITIATIVES
For more information visit http://www.researchandmarkets.com/research/7rc6qw/cancer_stem_cell
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets